General paperNon-enzymic oxidation of Cysteinyldopa (cas 19641-92-0) catalyzed by metallic ions
-
Add time:09/03/2019 Source:sciencedirect.com
1.1. Evidence is presented that under physiological conditions Cysteinyldopa (cas 19641-92-0) behaves similarly to catecholamines, e.g. adrenaline, in forming reversible complexes with various metallic cations.2.2. As a rule, these complexes are stable under anaerobic conditions, but readily autoxidize in the presence of O2 to give the 1,4-benzothiazine acid (II) corresponding to one of the postulated intermediates in the biosynthesis of phaeomelanic pigments.3.3. Copper catalyzed oxidation of cysteinyldopa proceeds differently to give the red-purple trichochrome F presumably via decarboxylation and oxidative coupling of the same benzothiazine intermediate.4.4. The relevance of these in vitro experiments to the metabolism of cysteinyldopa is briefly discussed.
We also recommend Trading Suppliers and Manufacturers of Cysteinyldopa (cas 19641-92-0). Pls Click Website Link as below: cas 19641-92-0 suppliers
Prev:Development of a mass spectrometry method for the determination of a melanoma biomarker, 5-S-Cysteinyldopa (cas 19641-92-0), in human plasma using solid phase extraction for sample clean-up
Next:Characterisation of 1,4-benzothiazine intermediates in the oxidative conversion of 5-S-Cysteinyldopa (cas 19641-92-0) to pheomelanins) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Regular paper5-S-Cysteinyldopa (cas 19641-92-0), a diffusible product of melanocyte activity, is an efficient inhibitor of hydroxylation/oxidation reactions induced by the Fenton system09/07/2019
- A pulse radiolysis investigation of the oxidation of the melanin precursors 3,4-dihydroxyphenylalanine (dopa) and the Cysteinyldopa (cas 19641-92-0)s09/06/2019
- Clinical investigation5-S-Cysteinyldopa (cas 19641-92-0) as Diagnostic Tumor Marker for Uveal Malignant Melanoma09/05/2019
- Characterisation of 1,4-benzothiazine intermediates in the oxidative conversion of 5-S-Cysteinyldopa (cas 19641-92-0) to pheomelanins09/04/2019
- Development of a mass spectrometry method for the determination of a melanoma biomarker, 5-S-Cysteinyldopa (cas 19641-92-0), in human plasma using solid phase extraction for sample clean-up09/02/2019
- Presence of Cysteinyldopa (cas 19641-92-0) in the mature bovine eye09/01/2019
- The first expedient entry to the human melanogen 2-S-Cysteinyldopa (cas 19641-92-0) exploiting the anomalous regioselectivity of 3,4-dihydroxycinnamic acid–thiol conjugation08/31/2019
- Case reportTreatment of Primary Melanoma of the Lung Monitored by 5-S-Cysteinyldopa (cas 19641-92-0) Levels08/30/2019
- The pheomelanin precursor 5-S-Cysteinyldopa (cas 19641-92-0) protects melanocytes from membrane damage induced by ultraviolet A radiation08/29/2019